About SonALAsense
SonALAsense is a company based in Berkeley (United States) founded in 2019 by Stuart Marcus.. SonALAsense has raised $13.7 million across 6 funding rounds from investors including HHS. SonALAsense offers products and services including SONALA-001 and Exablate 4000 Type 2. SonALAsense operates in a competitive market with competitors including QV Bioelectronics and SonoTarg, among others.
- Headquarter Berkeley, United States
- Founders Stuart Marcus
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$13.7 M (USD)
in 6 rounds
-
Latest Funding Round
$15 M (USD), Debt – Conventional
Nov 17, 2023
- Investors
-
Employee Count
Employee Count
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of SonALAsense
SonALAsense offers a comprehensive portfolio of products and services, including SONALA-001 and Exablate 4000 Type 2. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Tumor-targeting drug for sonodynamic therapy to destroy cancer cells.
MR-guided focused ultrasound for noninvasive cancer treatment.
Unlock access to complete
Unlock access to complete
Funding Insights of SonALAsense
SonALAsense has successfully raised a total of $13.7M across 6 strategic funding rounds. The most recent funding activity was a Debt – Conventional round of $15 million completed in November 2023. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 6
- Last Round Debt – Conventional — $15.0M
-
First Round
First Round
(01 Jan 2019)
- Investors Count 1
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Nov, 2023 | Amount | Debt – Conventional - SonALAsense | Valuation |
investors |
|
| Feb, 2023 | Amount | Series B - SonALAsense | Valuation |
investors |
|
| Feb, 2021 | Amount | Series A - SonALAsense | Valuation |
investors |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in SonALAsense
SonALAsense has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include HHS. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Public health and human services are overseen by HHS.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by SonALAsense
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - SonALAsense
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Sonalasense Comparisons
Competitors of SonALAsense
SonALAsense operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as QV Bioelectronics and SonoTarg, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Electrotherapy devices for brain tumor treatment are manufactured.
|
|
| domain | founded_year | HQ Location |
Develops microbubble-based drug delivery for targeted cancer treatment and ultrasound activation.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Sonalasense
Frequently Asked Questions about SonALAsense
When was SonALAsense founded?
SonALAsense was founded in 2019.
Where is SonALAsense located?
SonALAsense is headquartered in Berkeley, United States. It is registered at Berkeley, California, United States.
Who is the current CEO of SonALAsense?
Stuart Marcus is the current CEO of SonALAsense. They have also founded this company.
Is SonALAsense a funded company?
SonALAsense is a funded company, having raised a total of $13.7M across 6 funding rounds to date. The company's 1st funding round was a Series A of $3.93M, raised on Jan 01, 2019.
What does SonALAsense do?
SonALAsense was founded in 2019 in Berkeley, United States. Focus is placed on biotechnology for therapeutic solutions targeting cancer, neurological disorders, and related conditions. A non-invasive drug-device combination therapy, known as ALA sonodynamic therapy, is developed for recurrent glioblastoma multiforme. This approach integrates an MRI-guided focused ultrasound device with aminolevulinic acid to deliver cancer-specific effects. Operations center on noninvasive treatments for glioblastoma multiforme and similar applications.
Who are the top competitors of SonALAsense?
SonALAsense's top competitors include QV Bioelectronics and SonoTarg.
What products or services does SonALAsense offer?
SonALAsense offers SONALA-001 and Exablate 4000 Type 2.
Who are SonALAsense's investors?
SonALAsense has 1 investor. Key investors include HHS.